Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Factor Xa inhibitor selected for clinical trials at Berlex Biosciences

April 8, 1998

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Merck & Co. designates thrombin inhibitor for clinical development

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

FDA advisory committee will discuss Aggrastat NDA later this week

April 7, 1998

FDA approves another new indication for Lovenox

April 7, 1998

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Orally active thrombin inhibitor discovered at Pfizer shows good tolerance in phase I

April 6, 1998

Amidino derivatives for thrombosis reported by Astra

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...